Editor profile
Editor, Market Intelligence & Industry Briefs
Amira Al-Mansour coordinates real-time updates on MedTech funding rounds, corporate M&A, and clinical trial results. She tracks high-frequency market signals for industry leaders.
amira.al-mansour@medtechdaily.orgMedical interoperability enables healthcare professionals to instantly access patients' complete medical histories through data sharing, avoiding duplicate tests and improving diagnostic efficiency and patient experience.
Advita Ortho presented nine studies at CAOS 2026, showcasing AI-generated shoulder digital twins, automated planning, and surgical navigation for shoulder, knee, and ankle procedures.
MiniMed launches the Abbott-manufactured Instinct continuous glucose monitor in Europe, targeting over 4.5 million Abbott CGM users, aiming to drive insulin pump sales growth through sensor selection.
China's "Regulations on the Clinical Research and Translational Application of Biomedical New Technologies" (Order 818) establishes a new commercialization pathway for advanced therapies such as cell and gene therapy, allowing clinical translation and charging fees in tertiary hospitals without drug registration from the National Medical Products Administration. This signals China's intention to accelerate local innovation and standardize the drug development environment, and it is expected to become an important player in the development and manufacturing of advanced therapies.
As GLP-1 drugs evolve from injectables to oral, multi-target, and RNA therapies, the entire metabolic disease treatment market is undergoing profound changes. This article analyzes the latest industry trends, key company strategies, and development directions over the next 3-5 years.